November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
New COO at Hemab Therapeutics: Anant Murthy to Advance Rare Blood Disorder Treatments
Sep 2, 2025, 12:50

New COO at Hemab Therapeutics: Anant Murthy to Advance Rare Blood Disorder Treatments

 

Hemab Therapeutics posted on X:

”Hemab is growing fast, and we’re thrilled to announce our new Chief Operating Officer, Anant Murthy, PhD.

In this new role, Dr. Murthy will lead the company’s global efforts in market access, launch, and commercialization, bringing Hemab’s promising pipeline of treatments for Glanzmann thrombasthenia, Von Willebrand disease,  and other neglected blood clotting disorders with high unmet needs to patients worldwide.

Read more here.”

 

Stay updated with Hemostasis Today.